On September 1, 2021 iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immune-oncology therapeutics for patients, reported that company management will participate in five upcoming virtual investor conferences in September (Press release, iTeos Therapeutics, SEP 1, 2021, View Source [SID1234587115]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

KBC Securities Life Sciences Conference
Format: Management one-on-ones
Date: September 7, 2021
Wells Fargo Virtual Healthcare Conference
Format: Management one-on-ones
Date: September 9-10, 2021
Morgan Stanley 19th Annual Global Healthcare Conference
Format: Management one-on-ones
Date: September 9-10 and 13-15, 2021
H.C. Wainwright 23rd Annual Global Investment Conference
Format: On demand presentation by Michel Detheux, Ph.D., President and Chief Executive Officer
Date/Time: Monday, September 13, 2021 at 7:00 a.m. ET
Cantor Fitzgerald Global Healthcare Conference
Format: Live presentation by Michel Detheux, Ph.D., President and Chief Executive Officer
Date/Time: Monday, September 27, 2021 at 2:40 p.m. ET
Audio webcasts of the presentations will be available on the Investor section of the company’s website at View Source An archived replay will be available for approximately 30 days following the presentation.